HER2DX® recognized by TIME as one of the best inventions of 2022
HER2DX® was highlighted in Times 'Medical Care' category, which publicizes inventions that are successfully implemented in medical practice.
HER2DX® was highlighted in Times 'Medical Care' category, which publicizes inventions that are successfully implemented in medical practice.
Since it was founded, it has published over 30,000 scientific articles, which have allowed us to gain a better understanding of the main diseases in1
Varicose veins cannot always be prevented, but following certain recommendations may stop their progress.
The Japanese company, leader in screening for colorectal cancer worldwide, will fund the first phase of a multicenter clinical trial led by Antoni Ca1
On Wednesday 16 and Thursday 17 November, in the framework of Science Week 2022, IDIBAPS takes the laboratories to the street and organizes scientifi1
On 3 November 2022, the TV3 Marató Foundation announced the research projects that will receive funding from the 2021 Marató, dedicated to mental dis1
It usually affects 1% of the general population but is more prevalent in women. Since it is confused with stress, it is usually diagnosed when the di1
The visit is part of a new communication project aimed at raising awareness of the research carried out at the Institute among patients and patient a1
The job of the rehabilitation doctor and the physiotherapist consists of working together with other specialists such as occupational therapists, spe1
Over the next three years, Eduard Vieta and his team will lead the Clínic-IDIBAPS contribution to this project, which has the support of the European1